Recombinant Human EPHA2 Protein (28-328 aa), His-Myc-tagged
Cat.No. : | EPHA2-2515H |
Product Overview : | Recombinant Human EPHA2 Protein (28-328 aa) is produced by E. coli expression system. This protein is fused with a 10xHis tag at the N-terminal and a Myc tag at the C-terminal. Research Area: Cardiovascular. Protein Description: Partial. |
- Specification
- Gene Information
- Related Products
Description : | Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand-independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis. |
Source : | E. coli |
Species : | Human |
Tag : | His-Myc |
Form : | Tris-based buffer,50% glycerol |
Molecular Mass : | 38.3 kDa |
Protein length : | 28-328 aa |
AA Sequence : | EVVLLDFAAAGGELGWLTHPYGKGW DLMQNIMNDMPIYMYSVCNVMSGDQ DNWLRTNWVYRGEAERIFIELKFTV RDCNSFPGGASSCKETFNLYYAESD LDYGTNFQKRLFTKIDTIAPDEITV SSDFEARHVKLNVEERSVGPLTRKG FYLAFQDIGACVALLSVRVYYKKCP ELLQGLAHFPETIAGSDAPSLATVA GTCVDHAVVPPGGEEPRMHCAVDGE WLVPIGQCLCQAGYEKVEDACQACS PGFFKFEASESPCLECPEHTLPSPE GATSCECEEGFFRAPQDPASMPCTR P |
Purity : | > 85% as determined by SDS-PAGE. |
Notes : | Repeated freezing and thawing is not recommended. Store working aliquots at 4 centigrade for up to one week. |
Storage : | The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of liquid form is 6 months at -20 centigrade/-80 centigrade. The shelf life of lyophilized form is 12 months at -20 centigrade/-80 centigrade. |
Concentration : | A hardcopy of COA will be sent along with the products. Please refer to it for detailed information. |
Gene Name : | EPHA2 EPH receptor A2 [ Homo sapiens ] |
Official Symbol : | EPHA2 |
Synonyms : | EPHA2; EPH receptor A2; ECK, EphA2; ephrin type-A receptor 2; soluble EPHA2 variant 1; ECK; CTPA; ARCC2; CTPP1; |
Gene ID : | 1969 |
mRNA Refseq : | NM_004431 |
Protein Refseq : | NP_004422 |
MIM : | 176946 |
UniProt ID : | P29317 |
Products Types
◆ Recombinant Protein | ||
EPHA2-3378H | Recombinant Human EPHA2 Protein, GST-tagged | +Inquiry |
Epha2-954M | Recombinant Mouse Epha2 Protein, MYC/DDK-tagged | +Inquiry |
EPHA2-0986H | Recombinant Human EPHA2 Protein (R561-I976), GST tagged | +Inquiry |
EPHA2-321H | Recombinant Human EPHA2 Protein, MYC/DDK-tagged, C13 and N15-labeled | +Inquiry |
Epha2-915MB | Recombinant Mouse Epha2 protein(Met1-Asn535), His & Avi-tagged, Biotinylated | +Inquiry |
◆ Lysates | ||
EPHA2-001HCL | Recombinant Human EPHA2 cell lysate | +Inquiry |
EPHA2-1072HCL | Recombinant Human EPHA2 cell lysate | +Inquiry |
EPHA2-2138MCL | Recombinant Mouse EPHA2 cell lysate | +Inquiry |
◆ Assay kits | ||
Kit-0326 | EphA2 Kinase (Human) Assay/Inhibitor Screening Assay Kit | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionTherapeutic strategies for EPHA2 include inhibition of its expression, blocking its signal transduction pathway, and modulating its interaction with ligands. These strategies may involve the use of small molecule inhibitors, antibodies, or other types of therapeutics.
The expression level of EPHA2 is associated with the occurrence and progression of a variety of diseases. For example, in tumors such as lung, breast, and colorectal cancer, EPHA2 expression levels may be elevated and correlated with the degree of malignancy and poor prognosis of the tumor.
In some tumors, EPHA2 expression levels are associated with poor prognosis in patients. For example, patients with lung cancer who express EPHA2 often have shorter survival. Therefore, the expression level of EPHA2 may be one of the indicators to predict tumor prognosis.
Some diseases can be diagnosed by measuring EPHA2 expression levels, such as immunohistochemistry, western blotting, and real-time PCR.
Yes, EPHA2 can be used as a target for the treatment of certain diseases. For example, inhibition of EPHA2 expression can inhibit tumor growth and spread, so EPHA2 can serve as a potential therapeutic target. In addition, regulating the expression level of EPHA2 may also be helpful in the treatment of diseases such as the nervous system and cardiovascular system.
EPHA2 can promote cancer metastasis and affect the spread and spread of cancer by regulating processes such as invasion and migration of tumor cells. Therefore, inhibition of EPHA2 expression or blocking its signal transduction pathway may have a potential therapeutic effect on inhibiting cancer metastasis.
Customer Reviews (3)
Write a reviewThe protein has low cytotoxicity.
EPHA2 has good stability, and the test results of heat resistance, acid and alkali resistance and protease degradation resistance are good.
Kinetic parameters such as enzymatic reaction rate and binding affinity were tested, and the protein performed well.
Ask a Question for All EPHA2 Products
Required fields are marked with *
My Review for All EPHA2 Products
Required fields are marked with *
Inquiry Basket